2013-09-16Zeitschriftenartikel
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century
Pulte, Dianne; Barnes, Benjamin; Jansen, Lina; Eisemann, Nora; Emrich, Katharina; Gondos, Adam; Hentschel, Stefan; Holleczek, Bernd; Kraywinkel, Klaus; Brenner, Hermann
Introduction: The advent of tyrosine kinase inhibitors has produced 5-year survival of 90 + % for chronic myelocytic leukemia (CML) patients in clinical trials. However, population level survival has been lower, especially ...